Ikris Pharma Network is a fast growing global pharmaceutical consultancy and service company based in India having unique business model dedicated to delivering hard to access/unapproved medicines through named patient import program in Asian countries. We have network which can operate efficiently in complex regulatory environment and ensure 100% legal compliance to deliver such lifesaving medicines to the patients.

We also take pride in being only company in India having team of experienced professionals covering major Hospitals/Institution and Key Opinion Leaders across different therapeutic specialties in India. We have assisted more than 1200 patients to get their medicines through named patient import across Asia so far.

What we do

Ikris Pharma Network assist in documentation for legally compliant import of medicines for personal use, connect with genuine suppliers of such lifesaving medicines and help in delivery through appropriate logistics to address unmet medical needs

How we do

There are some medicines which have been approved recently in USA or Europe but not yet approved in India or any other countries. They are not permitted to be imported or marketed commercially. However, they may be required for the treatment of patients to save their lives who have exhausted all other available treatment options in their country. Named Patient Program is to facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, that permits the patient to import these medicine in small quantity. Similar regulatory provision also exist in other countries.

We assist patient in preparing legal documents for import and connecting them with authorized suppliers in USA and Europe to secure genuine products.

Documents required for importing medicines for personal use (in India)

  • Doctor’s Prescription
  • Patient’s Medical History
  • Patient’s Photo ID card
  • Application for permission in Form 12A

Upon receiving this confirmation, our Belgium office will raise Pro-Forma Invoice containing details of medicine, price, shipment cost and all other charges applicable. Pro-Forma Invoice will also have supplier’s license number, contact and Bank details to proceed further.
Patient will be required to make online payment using bank details mentioned in Pro-forma Invoice.

Although we do not provide any representation before any Indian authority. We routinely advise on the procedure and standard documentation required to obtain an import license and Custom Duty Exemptions Certificate (CEDEC) for obtaining clearance of medicine order through customs in India.
Medicine will be shipped once all documents are ready and money received in Supplier’s account in Belgium. Shipment service tracking will be provided. We will update patient at every step of transaction.

Our Office in Belgium

We have our own setup in Belgium which works as our sourcing office. This office is named as Ikris Pharma International (IPI) and full information is available through

IPI works under EU compliant SOPs having EU Good Distribution Practice (GDP) certificate from Belgian Federal Agency for medicines and health products.

Advantage IKRIS:
  • Assisting medicines import, only through named patient import license or regulatory approvals
  • Assisted more than 1200 patients in getting medicines through named patient import
  • Having own EU GDP compliant office in Belgium for genuine and reliable medicines sourcing
  • Special care for transporting temperature sensitive medicines (2-8C) through validated cold chain solutions (EXAM)*
  • Only company having pan India presence – Experienced professionals posted at all major cities for any assistance
  • Exclusive tie up with Orphan Europe** for accessing their medicines for rare diseases.
  • We help in accessing medicines for genetic metabolic disorder and other rare diseases as well


*EXAM packaging solution
** Orphan Europe, France. Recordati Group company

Drug Licence

Authorization Letter – for OE products

Buy OE(Orphan Europe) Products

Compliance with Good Distribution Practices
according to EU Directive 2001/83/EC

issued by the Belgian Federal Agency for
Medicines and Health Products


Arab Health Exhibition and Congress

Featured Services

ikris Pharma Network (H. O.)

Ikris Pharma Legal Documentation

Ikris ( Named Patient Import )

Interview of ikris pharma network